Vera Therapeutics, Inc.
VERA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001831828
In the last 90 days, Vera Therapeutics, Inc. insiders filed 0 open-market purchases and 5 sales; 219 institutions reported holding it in 13F filings for Q2 2026, worth $3.34B in total; no superinvestor holds it.
Q1 2022 vs. Q4 2021
How the institutions holding Vera Therapeutics, Inc. changed between Q4 2021 and Q1 2022.
All holders in Q1 2022All holders in Q4 2021
| Measure | Q4 2021 | Q1 2022 | Change |
|---|---|---|---|
| Holders | 37 | 50 | +13 |
| Shares | 14.1M | 19.7M | +5.62M (+40.0%) |
| Value | $374.9M | $468.9M | +$94.0M (+25.1%) |
New holders (15)
Institutions that held Vera Therapeutics, Inc. at the end of Q1 2022 but not at the end of Q4 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Ra Capital Management, L.P. | 1,966,084 | $46.2M | 1.01% |
| Vivo Capital, LLC | 666,666 | $15.7M | 1.08% |
| Baker Bros. Advisors LP | 333,333 | $7.83M | 0.04% |
| Millennium Management LLC | 133,500 | $3.14M | 0.00% |
| Maven Securities LTD | 64,240 | $1.51M | 0.31% |
| Polar Asset Management Partners Inc. | 60,000 | $1.41M | 0.02% |
| Ensign Peak Advisors, Inc | 13,277 | $312.0K | 0.00% |
| Rhumbline Advisers | 10,385 | $244.0K | 0.00% |
| MetLife Investment Management | 8,881 | $208.6K | 0.00% |
| Barclays PLC | 2,222 | $53.0K | 0.00% |
| UBS Group AG | 2,009 | $47.0K | 0.00% |
| Amalgamated Bank | 1,438 | $34.0K | 0.00% |
| Amalgamated Financial Corp. | 1,438 | $34.0K | 0.00% |
| Metropolitan Life Insurance Co | 1,041 | $24.5K | 0.00% |
| US Bancorp | 1,000 | $23.0K | 0.00% |
Sold out (2)
Institutions that held Vera Therapeutics, Inc. at the end of Q4 2021 and filed for Q1 2022 without it.
| Institution | Shares, Q4 2021 | Value, Q4 2021 |
|---|---|---|
| Parkman Healthcare Partners LLC | 21,555 | $576.0K |
| Jane Street Group, LLC | 8,287 | $221.0K |